Brief: Rubius Therapeutics Q3 Loss Per Share $0.59

Rubius Therapeutics

14/11/2019 13:53

Nov 14 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS THIRD QUARTER 2019 FINANCIAL
RESULTS
AND OPERATIONAL PROGRESS
    * Q3 LOSS PER SHARE $0.59
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.53 -- REFINITIV IBES
DATA
    * RUBIUS THERAPEUTICS - AS OF SEPT 30,CASH, CASH EQUIVALENTS
AND
INVESTMENTS WERE $324.7 MILLION AS COMPARED TO $404.1 MILLION AS
OF DECEMBER 31, 2018

Source text for Eikon:  ID:nGNX3NlTJ4 
Further company coverage:  RUBY.O 

 ((Briefs@thomsonreuters.com;))